On October 5, 2020 Exicure, Inc. (Nasdaq: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA) constructs, reported a presentation at the Chardan Virtual 4th Annual Genetic Medicines Conference on Monday, October 5, 2020 (Press release, Exicure, OCT 5, 2020, View Source [SID1234568111]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Monday, October 5, 2020

Time: 11:00 – 11:25 AM Eastern Time

Location: Virtual Webcast

The presentation will be available for live streaming via View Source

Replays of the webcast will be available on Exicure’s website for 30 days following the webcast.